iBio, Inc.
IBIONASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $74.69M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.73$3.82
- Volume (live)
- -
- Avg. volume (3M)
- 826.93K
iBio (IBIO) Stock Price & Financial Analysis
iBio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.71 - $0.78 |
|---|---|
| 52-Week High | $3.82 |
| 52-Week Low | $0.73 |
| Open | $0.77 |
| Volume (last close) | 655.13K |
| Average Volume (3M) | 826.93K |
| Revenue (TTM) | 100.00K |
|---|---|
| Net Income (TTM) | -32.81M |
| Free Cash Flow (TTM) | -23.80M |
| EPS (TTM) | −$0.38 |
| Profit Margin | -32813.00% |
| Operating Margin | -27635.00% |
| Return on Equity (ROE) | -38.28% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 74.69M |
|---|---|
| Shares Outstanding | 104.06M |
| Price to Sales (P/S) | 746.94 |
| Price to Book (P/B) | 0.87 |
| EV/EBITDA | -0.85 |
| 50-Day MA | $1.20 |
|---|---|
| 200-Day MA | $1.76 |
| 1-Year Change | −38.27% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
iBio at a Glance
As of the Oct 23, 2026 close, iBio (IBIO) has a market capitalization of $74.69M. The stock trades at 746.9× sales. Over the trailing twelve months it lost $32.81M on revenue of $100.00K and burned $23.80M of free cash flow. Revenue fell 75.0% year over year.
As of its latest reported balance sheet, it holds $56.40M in cash and securities against $2.20M of debt, a net cash position of $54.20M.
iBio does not currently pay a dividend.
The share price is down 38.3% over the past year. At $0.72 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.73 to $3.82, below its 200-day moving average of $1.76.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.00, 735.9% above the Oct 23, 2026 close.
Frequently Asked Questions About iBio
What is the current stock price for IBIO?
As of the Oct 23, 2026 close, IBIO stock trades at $0.72. The 52-week range is $0.73–$3.82, with a day range of $0.71–$0.78.
What is the P/E ratio for IBIO?
The P/E ratio (Price-to-Earnings) for IBIO is shown in the Key Statistics section. This valuation metric helps compare iBio, Inc. to industry peers.
Does IBIO pay dividends?
iBio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IBIO?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for IBIO is Buy. The average 12-month price target is $6.00, a 735.9% upside from the Oct 23, 2026 close of $0.72.
What is the market cap of IBIO?
As of the Oct 23, 2026 close, iBio's market capitalization is $74.7M, classifying it as a micro-cap company. iBio operates in the Healthcare sector within the Biotechnology industry.